Komori
Tsubota Laboratory (4890) · InitiativeAdvanced

Creating new revenue opportunities by expanding into the cosmetics business

First written in FY2026-H1. 5 of 6 entries say "Advanced", first in 2026-05-14. Latest entry: FY2026.

6entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2026-H1Advanced2026-05-14 – FY20262025: 120252026: 52026
Same theme, other companies
Entry into the cosmetics business from a healthcare and research baseA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Moved together

"Commercialization of R&D Pipelines and Establishment of Post-Launch Royalty Revenue" moved the same way as this thread, in the same document, in 4 of its 6 moves.

444333★123456
  1. ★This thread
  2. 1Commercialization of R&D Pipelines and Establishment of Post-Launch Royalty Revenue4×
  3. 2Strengthening basic research4×
  4. 3Clinical Trial and Launch of TLM-003 Myopia Progression Prevention Eye Drops4×
  5. 4Global Out-Licensing and Royalty Monetization of TLM-001, a Treatment for Meibomian Gland Dysfunction3×
  6. 5TLG-001 Pivotal Verification Clinical Trial and Medical Device Approval3×
  7. 6Securing and Developing In-House Researchers and Business Personnel3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tsubota Laboratory yet. It last moved in the General Meetings of Shareholders of 2026-06-04: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Creating new revenue opportunities by expanding into the cosmetics business | Tsubota Laboratory Incorporated (4890) | Komori